[The EMPHASIS-HF study]

G Ital Cardiol (Rome). 2011 May;12(5):315-8. doi: 10.1714/643.7495.
[Article in Italian]
No abstract available

MeSH terms

  • Aldosterone / physiology
  • Biomarkers
  • Canrenone / chemistry
  • Canrenone / therapeutic use
  • Cause of Death
  • Double-Blind Method
  • Early Termination of Clinical Trials*
  • Eplerenone
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Hospitalization / statistics & numerical data
  • Humans
  • Hyperkalemia / chemically induced
  • Male
  • Mineralocorticoid Receptor Antagonists / adverse effects
  • Mineralocorticoid Receptor Antagonists / chemistry
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Models, Cardiovascular
  • Molecular Structure
  • Multicenter Studies as Topic / methods
  • Multicenter Studies as Topic / statistics & numerical data*
  • Myocardial Infarction / complications
  • Patient Selection
  • Randomized Controlled Trials as Topic / methods
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Renin-Angiotensin System / drug effects
  • Renin-Angiotensin System / physiology
  • Research Design*
  • Risk
  • Spironolactone / adverse effects
  • Spironolactone / analogs & derivatives*
  • Spironolactone / chemistry
  • Spironolactone / pharmacology
  • Spironolactone / therapeutic use

Substances

  • Biomarkers
  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Aldosterone
  • Eplerenone
  • Canrenone